Partnership Limited Center Management Jingran Tianjin Net Worth & Insider Trades
Partnership Limited Center Management Jingran Tianjin Casi Pharmaceuticals, Inc
What is Partnership Limited Center Management Jingran Tianjin's Net Worth?
The current estimated net worth of Casi Pharmaceuticals, Inc's Partnership Limited Center Management Jingran Tianjin is estimated to be about $33.04M . Partnership Limited Center Management Jingran Tianjin owns about 8,498,765 units of Casi Pharmaceuticals, Inc common stock. In the last 2 years at Casi Pharmaceuticals, Inc, Partnership Limited Center Management Jingran Tianjin has sold an estimated value of $0 worth.
What is Partnership Limited Center Management Jingran Tianjin's Past Insider Trading?
Partnership Limited Center Management Jingran Tianjin's largest purchase order was 3,753,855 units , worth over $4.47M on June 29, 2016. In total, Partnership Limited Center Management Jingran Tianjin has made about 2 transactions over 2 years of their time at Casi Pharmaceuticals, Inc. Partnership Limited Center Management Jingran Tianjin usually trades in November and June, with the busiest year in 2018 and 2016.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SPARKLE BYTE LTD, SNOW MOON LTD, PARTNERSHIP LIMITED CENTER MANAGEMENT JINGRAN TIANJIN, HE XIE AI QI INVESTMENT MANAGEMENT BEIJING CO LTD, Jianguang Li, Dongliang Lin, Fei Yang, Hugo Shong
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Partnership Limited Center Management Jingran Tianjin's' Mailing Address?
- Mailing address is RM 1704-4920, Kuang Shi Intl Tower A Xiangluowan Business Ctr Free Trade Zone Tianjin F4 00000 China
Casi Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
Wei-Wu He, Ph.D. | 2020 | $577,656 | - | - | - | - | $241,831 | $819,487 |
Wei-Wu He, Ph.D. | 2019 | $423,848 | - | - | $8,600,000 | - | $241,555 | $9,265,103 |
Wei (Larry) Zhang | 2020 | $437,094 | - | - | - | - | $278,675 | $715,769 |
Wei (Larry) Zhang | 2019 | $339,207 | - | - | $450,000 | - | $166,889 | $985,186 |
Alexander Zukiwski, MD | 2020 | $414,529 | - | - | - | - | $28,250 | $442,779 |
Alexander Zukiwski, MD | 2019 | $407,600 | $100,000 | - | $426,000 | - | $27,750 | $961,350 |
Weihao Xu | 2020 | $14,583 | - | - | $1,440,000 | - | - | $1,454,583 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/895051/000110465921063604/tm2114348d2_def14a.htm
What are Casi Pharmaceuticals, Inc's Past Insider Trades?
Casi Pharmaceuticals, Inc's most recent insider trade came on September 8, 2022 by James Huang who bought 55,573 units worth $229.66K . In the last 6 years, insiders at Casi Pharmaceuticals, Inc have sold an estimated value of $5.53M and bought an estimated value of $56.36M worth of shares. Insider trading is most common in June, with the busiest year in 2016. The most active traders at the company are Wei-Wu He, Chairman and CEO, James Huang, Director, and Cynthia W Hu, COO .
CASI Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |